Invesco Health Care S&P US Select Sector UCITS ETF Acc (XLVS.L) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with XLVS.L. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.
Cheapest Alternatives to XLVS.L
XLVS.L charges 0.14% annually. There is 1 ETF in the Health & Biotech Equities category with a lower expense ratio, going as low as 0.12%.
| Symbol | Name | Expense Ratio | AUM | Inception | |
|---|---|---|---|---|---|
| Xtrackers MSCI USA Health Care UCITS ETF 1D | 0.12% | 644.55M | Sep 2017 | XLVS.L vs XSHC.L | |
| Invesco US Health Care Sector UCITS ETF | 0.14% | 343.20M | Dec 2009 | XLVS.L vs XLVP.L | |
| iShares S&P 500 Health Care Sector UCITS ETF USD (... | 0.15% | 2.55B | Jun 2020 | XLVS.L vs IUHC.L | |
| SPDR S&P US Health Care Select Sector UCITS ETF | 0.15% | — | Jul 2015 | XLVS.L vs GXLV.L | |
| SPDR MSCI Europe Health Care UCITS ETF | 0.18% | — | Dec 2014 | XLVS.L vs HEAE.L |
Best Risk-Adjusted Alternatives to XLVS.L
XLVS.L has a PortfoliosLab risk / return rank of 28. There are 15 ETFs in the Health & Biotech Equities category with higher risk-adjusted ranks, going as high as 76.
| Symbol | Name | Risk / Return Rank | AUM | Inception | |
|---|---|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF | 76 | 624.54M | Oct 2017 | XLVS.L vs BTEK.L | |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dis... | 72 | 55.04M | Mar 2018 | XLVS.L vs BTEE.L | |
| Invesco Nasdaq Biotech UCITS ETF | 72 | 407.93M | Nov 2014 | XLVS.L vs SBIO.L | |
| Global X Genomics & Biotechnology UCITS ETF | 62 | 20.00M | Nov 2021 | XLVS.L vs GNOG.L | |
| WisdomTree BioRevolution UCITS ETF USD Acc | 61 | 12.52M | Dec 2021 | XLVS.L vs WBIO.L |
Top Performing XLVS.L Alternatives (YTD)
XLVS.L is at -2.10% YTD. There are 18 ETFs in the Health & Biotech Equities category with higher YTD returns, going as high as 12.27%.
| Symbol | Name | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|
| Global X Genomics & Biotechnology UCITS ETF | 12.27% | 20.00M | Nov 2021 | XLVS.L vs GNOG.L | |
| WisdomTree BioRevolution UCITS ETF USD Acc | 10.42% | 12.52M | Dec 2021 | XLVS.L vs WBIO.L | |
| First Trust NYSE Arca Biotechnology UCITS ETF Acc | 8.97% | 9.55M | May 2020 | XLVS.L vs FBT.L | |
| iShares Nasdaq US Biotechnology UCITS ETF | 4.86% | 624.54M | Oct 2017 | XLVS.L vs BTEK.L | |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dis... | 4.58% | 55.04M | Mar 2018 | XLVS.L vs BTEE.L |
Lowest Volatility Alternatives to XLVS.L
XLVS.L has 15.07% 1-year volatility. There are 6 ETFs in the Health & Biotech Equities category with lower 1-year volatility, going as low as 13.70%.
| Symbol | Name | Volatility 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| SPDR MSCI World Health Care UCITS ETF | 13.70% | — | Apr 2016 | XLVS.L vs HEAW.L | |
| Lyxor UCITS MSCI World Health Care TR C-USD | 14.52% | 913.84M | Aug 2010 | XLVS.L vs HLTW.L | |
| Xtrackers MSCI World Health Care UCITS ETF 1C | 14.57% | 3.40B | Mar 2016 | XLVS.L vs XDWH.L | |
| Xtrackers MSCI USA Health Care UCITS ETF 1D | 14.72% | 644.55M | Sep 2017 | XLVS.L vs XSHC.L | |
| Invesco US Health Care Sector UCITS ETF | 14.76% | 343.20M | Dec 2009 | XLVS.L vs XLVP.L |
Lowest Drawdown Alternatives to XLVS.L
XLVS.L has a 1-year max drawdown of -10.45%. There are 7 ETFs in the Health & Biotech Equities category with shallower 1-year drawdowns, going as shallow as -6.89%.
| Symbol | Name | Max Drawdown 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF | -6.89% | 624.54M | Oct 2017 | XLVS.L vs BTEK.L | |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dis... | -7.63% | 55.04M | Mar 2018 | XLVS.L vs BTEE.L | |
| Invesco Nasdaq Biotech UCITS ETF | -7.64% | 407.93M | Nov 2014 | XLVS.L vs SBIO.L | |
| L&G Pharma Breakthrough UCITS ETF | -9.93% | 14.12M | Jan 2018 | XLVS.L vs BIGT.L | |
| Lyxor UCITS MSCI World Health Care TR C-USD | -10.12% | 913.84M | Aug 2010 | XLVS.L vs HLTW.L |
Other ETFs from Invesco
The 10 most viewed Invesco ETFs shown here include EQQQ.L, XLKQ.L, SPXP.L and span 5 categories. AUM among these funds goes as high as $42B.
| Symbol | Name | Category | Risk / Return Rank | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|---|---|
| Invesco EQQQ NASDAQ-100 UCITS ETF | Nasdaq-100 | 78 | 19.86% | 15.17B | Dec 2002 | XLVS.L vs EQQQ.L | |
| Invesco Technology S&P US Select Sector UCITS ETF ... | Technology Equities | 73 | 23.81% | 1.76B | Dec 2009 | XLVS.L vs XLKQ.L | |
| Invesco S&P 500 UCITS ETF | S&P 500 | 83 | 10.55% | 41.77B | May 2010 | XLVS.L vs SPXP.L | |
| Invesco EQQQ Nasdaq-100 UCITS ETF GBP Hdg Acc | Nasdaq-100 | 73 | 18.86% | 15.14B | Oct 2017 | XLVS.L vs EQGB.L | |
| Invesco FTSE All-World UCITS ETF Acc | Global Equities | 86 | 11.92% | 3.10B | Feb 2024 | XLVS.L vs FWRG.L | |
| Invesco Dow Jones Islamic Global Developed Markets... | Global Equities | 76 | 15.04% | 1.13B | Jan 2022 | XLVS.L vs IGDA.L | |
| Invesco FTSE All-World UCITS ETF USD Dist | Global Equities | 86 | 11.87% | 3.10B | Feb 2024 | XLVS.L vs FTWG.L | |
| Invesco Physical Gold A | Precious Metals | 40 | 3.97% | 24.12B | Jun 2009 | XLVS.L vs SGLP.L | |
| Invesco EQQQ NASDAQ-100 UCITS ETF | Nasdaq-100 | 75 | 19.55% | 20.41B | Dec 2002 | XLVS.L vs EQQU.L | |
| Invesco FTSE All-World UCITS ETF USD Accumulation | Global Equities | 73 | 11.59% | 4.16B | Feb 2024 | XLVS.L vs FWRA.L |
Often Compared With XLVS.L
Investors most often compare XLVS.L with GLD, IGLN.L, QTOP. These 20 comparison targets span 7 categories, based on PortfoliosLab usage data.
Compare XLVS.L with Any Fund or Stock
Compare XLVS.L with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.
Pair XLVS.L with funds that move differently
Invesco Health Care S&P US Select Sector UCITS ETF Acc alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to XLVS.L.
Explore XLVS.L Diversifiers